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The authors regret that the reported non-synonymous mutation
L550V in the PfcPhers gene is a synonymous mutation. We would like to
correct this information in the manuscript.
In the Results section, second paragraph, it should read: “The L550V
mutation was not identiﬁed in the set of global ﬁeld isolates considered
here. At this position we detected a synonymous mutation.” In the
Discussion, second paragraph, this sentence can be omitted “From these
observations, we speculate that for new antimalarial compounds acting
on the PfcPhers gene, acquired resistance may occur more rapidly …”.
L550V should be omitted from Tables 1 and 2 and Suppl. Table 1.
The authors would like to apologies for any inconvenience caused.
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